Hematology and Oncology
Home Hematology and Oncology
Cancer Cachexia Associated With Poor Outcomes
Findings at six and 12 months after treatment for advanced head and neck cancer
Interface Between Allergy, Oncology Explored
Position paper focuses on interface between allergic responses and cancer, immunotherapy
More Cognitive Difficulties for Patients After Chemotherapy
Breast cancer survivors report cognitive issues after chemo, through six-month follow-up
Zoledronic Acid Every 12 Weeks Noninferior in Bone Metastases
No increase in risk of skeletal events versus treatment every four weeks for bone metastases
December 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2016. This roundup includes...
No Effect for BUP TAP Catheter on Chronic Pain After Breast Recon
No difference in chronic postsurgical pain incidence for TAP catheter delivering bupivacaine, saline
BodyFIX Without Wrap Works for Radiotherapy Immobilization
Compared to two other immobilization devices, BodyFIX was preferred by staff
Uric Acid May Mark Progression for Nasopharyngeal Cancer
High pretreatment uric acid may be clinical biomarker for lung metastasis
Panel of 88 SNPs Predicts Breast CA Risk in Women at High Risk
SNP88 is independent of Tyrer-Cuzick model; improved prediction when combined multiplicatively
Triple-Negative Breast CA Risk Up for Blacks With Benign Breast Dz
Increased risk of TNBC among African-American women with prior diagnosis of benign breast disease
